Better Therapeutics Insider Trades

MCAD

Track insider trading activity from Better Therapeutics executives and directors. See which insiders are buying and selling MCAD stock.

Trades Last 12 Months

All Insider Trades for Better Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Perry David P 10% owner, Executive Chairman
Holding Value $25.2M 2,416,634 shares
Last Trade
Feb 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.76M 839,895 shares
$10.43
$10.43
Holding Value $178k 17,084 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 3,750 shares
$10.43
$10.43
Berman Mark A. Chief Medical Officer
Holding Value $4.67M 448,140 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 25,362 shares
$10.43
$10.43
Holding Value $1.64M 157,369 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 3,750 shares
$10.43
$10.43
Granger Elder Director
Holding Value $413k 39,601 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 3,750 shares
$10.43
$10.43
Karbe Frank Chief Executive Officer
Holding Value $5.49M 526,516 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$652k 62,500 shares
$10.43
$10.43
Holding Value $143k 13,750 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 3,750 shares
$10.43
$10.43
Wynholds Kristin Chief Product Officer
Holding Value $2.35M 225,631 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 25,362 shares
$10.43
$10.43
Miller Leslie A. Principal Accounting Officer
Holding Value $187k 17,937 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.4k 3,587 shares
$10.43
$10.43
Holding Value $10.8M 1,031,805 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 3,750 shares
$10.43
$10.43
Heinen Mark Chief Financial Officer
Holding Value $1.46M 139,723 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 54,000 shares
$10.43
$10.43
Appelbaum Kevin J 10% owner, Chief Executive Officer
Holding Value $39.1k 3,750 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.4k 1,000 shares
$10.43
$10.43
Liu Suying Director
Holding Value $295k 28,300 shares
Last Trade
Oct 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$310k 28,300 shares
$10.97
$10.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up